Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.957
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy65 - Real-World Data Analysis of Us Claims Data on Coagulation Factor Ix Dispensation and Expenditures in Patients With Severe Hemophilia B: Standard Half-Life vs. Extended Half-Life Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision

Turkish Journal of Haematology
Hematology
2019English

Discrepancies Between the One-Stage Clotting Assay and Chromogenic Assay in Patients With Hemophilia a Receiving Standard or Extended Half-Life Factor VIII Products in Clinical Settings

Thrombosis Research
Hematology
2020English

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

The Impact of Extended Half-Life Versus Conventional Factor Product on Hemophilia Caregiver Burden

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2018English

Psy112 - Factor Utilization Analysis of Extended Duration and Standard-Acting Recombinant Fviii Treatments for Severe Hemophilia a in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Multi-Center Post-Marketing Surveillance Study of Recombinant Factor VIII (Recombinate) in Previously Treated Patients With Hemophilia A

Japanese Journal of Thrombosis and Hemostasis
2005English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy